Introduction

1
Systems biology takes as its fundamental premise that biological systems can be best understood 2 through the relationships between their parts, rather than detailed examination of those parts in 3 isolation (Kitano, 2002) . Both systems approaches and purely reductionist alternatives will be useful in 4 different contexts, but systems analyses are particularly relevant to functional properties, where genes 5 or their downstream products generally must be selected to work in coordination. The groupings 6 defined by this coordinated activity may be assessed transcriptionally (Segal et networks to define relationships at a systems level. This framework not only captures important 10 involved in many functional processes, they are not characteristic of the dominant systems signal within 1 the data. Instead, these genes appear as outliers ( Figure 1B) . One way to think of these genes is to 2 consider disease, where systems break down or respond unusually to a perturbation. It might be that 3 genes acting uncharacteristically are of relevance to the dysfunction. We call these rogue actor genes 4 "functional outliers", and it is their possible disease significance which we hope to identify within this 5 work, focusing on rare disease. 6 Rare diseases pose both a statistical and functional problem in genomics; statistical, because they are 7 hard to power, and functional, because the biology may not naturally generalize from other systems. 8
The challenges notwithstanding, rare disorders are important to study both for their role in population 9 disease burden, which may be substantial in aggregate, and for the unique window they offer into 10 molecular processes underlying human biology (Forrest et al., 2011) . Rare diseases are close to an ideal 11 hunting ground in the search for functional outliers because they are usually caused by a few rare and 12 disruptive variants (Boycott et al., 2013) . Since functional outliers can arise in interest only by recurrence 13 across individuals (rather than shared activity in a common process), it is preferable to have a cohort 14 whose genetic architecture is similar so that gene-level recurrence may be more likely. The disease 15 cohort which we focus on is a recently reported set of families with rare mutations in the TAF1 16 transcription factor (TATA-Box Binding Protein Associated Factor 1) contributing to a well-defined 17 phenotypic alteration (O'Rawe et al., 2015). Genetically defined rare cohorts like the TAF1 syndrome are 18 extremely unusual, given the current state of genomic knowledge where complex diseases such as 19 schizophrenia and autism are (devastatingly) genetically heterogeneous. However, rare diseases defined 20 at the level of DNA variation may account for subtypes of many more common diseases (see, for 21 example this n= 15 cohort in autism (Bernier et al., 2014) ). TAF1 syndrome has a number of features 22 that may enrich for the presence of functional outliers within the expression data including a phenotype 23 not solely localized to the brain and a molecular basis where unusual or unbuffered expression 24 alterations may be likely (Lee and Young, 2013 ; O' Rawe et al., 2015) . In general, our viewpoint is that 1 the less the disease looks like a convergent regulatory response, the greater the chance we will enrich 2 for functional outliers. However, this is not a supposition upon which our analysis depends, merely a 3 factor which will have implications for the scope of applicability of our approach and findings. 4 In this work, we develop a means to characterize functional outliers, genes which are exhibiting 5 anomalous differential expression specifically in the context of the expression of the other genes in the 6 data. We first treat each of our pedigrees as a separate differential expression experiment, assess the 7 candidate gene list for systems convergence and determine the remainder not showing systems 8 convergence. We then exploit the known overlaps between our pedigrees to use recurrence of signals 9 across them -and only that -as our measure of significance for both classes of result. Within our 10 experimental paradigm, optimized to detect functional outliers, we find that most differential 11 expression exhibits expected co-variation between genes, but there are exceptions which can be 12 robustly characterized. It is these exceptions which are validated by the analysis of the cohort as a 13 whole. The most prominent functional outlier within our data is a highly plausible candidate to play a 14 role in TAF1 syndrome. We close our results by assessing the implications from our targeted family-15 based analysis to applying functional outlier detection in case-control experiments. Finally, we discuss 16 whether the unusually clear role functional outliers appear to play in TAF1 syndrome can be expected to 17 generalize to other disorders. 18 19 
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Results
1
Using co-expression as a filter to define unexpected differential expression 2
In this work, we rely on largescale co-expression meta-analysis to define functional relationships 3 between genes, not just as a standard method of capturing functional relationships (Lee et al., 2004) , 4 but also because it captures the expectation of co-incidence within a hit list derived from a differential 5 expression (DE) experiment in a purely technical sense (i.e., co-expression is co-variation of expression). 6
Many of the elements of our approach are relatively conventional (Robles et al., 2012) ; however, two 7 atypical elements are worth highlighting. First, our analysis is highly conservative; we aggregate across 8 individual networks thresholded as having any positive correlation at all (and then take the 9 complement). This would be overly permissive in identifying functional links and is therefore 10 conservative at identifying outliers, likely at a cost to performance. Second, we consider only positive 11 relationships. We will consider our DE lists directionally; i.e., treating positive and negative differential 12 expression as separate hit lists. In this context, only genes jointly positively differentially expressed can 13 be said to be expected to be part of the same list. A summary of our approach is detailed in Figure 2 (see 14 experimental procedures for more details). 15
To generate a common co-expression frequency network, we tally up all poorly co-expressed pairs 16 (Spearman's correlation coefficient r s <0) from 75 co-expression networks across 3,653 samples (see 17 experimental procedures and Figure 2A , experiments listed in Table S1 ). One potential problem with 18 filtering by co-expression for outliers is the possibility that outliers are simply unusual due to noise, in 19 the form of low expression. For example, the absence of joint expression might be observed because the 20 level of expression of these genes is weak or noisy. However, we see little relationship between the 21 average expression levels and the presence within our co-expression frequency network (Spearman's 22 correlation coefficient r s =0.03). Another possibility is that the genes are not measured or detected, 23
. CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/128439 doi: bioRxiv preprint first posted online Apr. 18, 2017; which would not affect the mean expression, but affect co-expression. Once again, we see close to no 1 relationship with the number of detected genes and the node degree of our co-expression frequency 2 network (Spearman's correlation coefficient r s =-0.03). As another check of the information within the 3 network, we measured its performance in terms of being able to recapitulate gene membership across 4
Gene Ontology (GO (Ashburner et al., 2000) ) terms through a simple machine learning method (Ballouz 5 et al., 2016) (see experimental procedures). As expected, the performance metric of 0.26 (AUROC) 6 across all GO terms is far lower than random (0.5), indicating the tally of non-relationships strongly 7 captures the absence of shared function. 8
Family-based differential expression is dominated by expected functional co-variation 9
We perform family-based differential expression in order to benefit from the shared genetics of the trio 10 (see experimental procedures), but potentially introducing other sources of common co-variation, which 11 our approach then looks to filter. For each pedigree, we sequence the RNA of the parents and proband, 12
and then compare the transcriptional profile of the proband to the parents ( Figure 2B) . We take the top 13 differential genes in both directions: those showing increased (up-regulated) or decreased (down-14 regulated) expression, and quantify and visualize their occurrence co-expression pattern in the co-15 expression frequency network ( Figure 2C) . Genes that are never seen as co-expressed will be closer to 1 16 (yellow/white), while those often seen are close to 0 (red). For each family, we observed large modules 17 (red blocks) in the data, indicating that those genes coming up as differentially expressed are also co-18 expressed and are also broadly reflective of functions expected to be represented in blood. We show a 19 representative plot of this co-expression matrix as a heatmap for family 3 ( Figure 3A , Table S2 for DE 20 gene lists for each family). We detect these co-expression modules or "co-expression blocks" through 21 hierarchical clustering of the genes to generate a dendrogram, and then a dynamic tree cutting 22 algorithm to identify the modules (see experimental procedures). 23
. CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/128439 doi: bioRxiv preprint first posted online Apr. 18, 2017; Our first observation is that the genes in these modules are clearly functionally related, or belong to 1 gene families. Since our co-expression frequency network is in essence an inverted co-expression 2 network, and co-expressed genes are believed to be functionally related, this was not surprising. The 3 genes within these co-expression blocks also dominate enrichment analysis within the DE hits. For 4 example, we see a large block of immunoglobulins, one of interferon-related proteins and a third related 5 to mitosis and the cell cycle in the top 100 up-regulated genes in family 3. Performing gene set 6 enrichment on this set of genes, we obtain 63 significant (after multiple hypothesis test correction) GO 7 terms enriched in our example shown in Figure 3B . Here, we show the overlap of the genes (rows) and 8 the enriched GO terms (columns). The genes are clustered as they are in part Figure 3A ; co-expression 9 blocks remain in one piece. We see that the significant GO terms contain genes almost exclusively in 10 those blocks, as indicated by the colored segments in the heatmap. 11
The terms enriched for are immune related (e.g., GO:0071357 cellular response to type I interferon, 12 p~3.27e-21) and cell-cycle related (e.g., GO:0000278 mitotic cell cycle p~0.008). Removing the co-13 expression modules weakens or removes most enrichment. That the genes showing expected functional 14 behavior (co-expression blocks) appear to be enriched for functions that seem likely to be confounds 15 provides some support for the possibility that their opposite (outliers) may represent dysfunction within 16 the data. Top DE enrichment results are listed in Table S3 . 17
Common functional variation can be robustly filtered 18
For each of our 6 families, we filter away these co-expression modules in order to retain the genes with 19 rare co-expression and unexpected (in the context of the other hits) differential expression. As an 20 example ( Figure 4A) , we show the genes left for assessment once we remove the co-expression blocks 21 from the top 100 down-regulated genes. In this case, we are left with 28 genes, and on average 42 genes 22 differentially expressed in each family. 23
. CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/128439 doi: bioRxiv preprint first posted online Apr. 18, 2017; We wished to test the dependence of our results on our parameter choices (i.e., the cutoffs for selecting 1 a gene to be termed DE and the size of the module to filter). We varied the number of DE genes we 2 consider by selecting thresholds from 10 to 1000 ( Figure 4B) . As we increase the number of genes, we 3 filter roughly between a third to two-thirds of the hits. We used the GO enrichment of the sets as a 4 check for the promiscuity of expected function since we observed that most enrichment is from these 5 co-expression blocks, as might be expected from the use of co-expression to predict function. We see an 6 increase in the number of significant terms returned as enriched as a function of the number of DE 7 genes considered ( Figure 4C , black line is the average across all families), and almost a complete loss of 8 enrichment once we filter the co-expression blocks (red line in Figure 4C with remaining families in 9
Figures S1-S2). A few GO terms did remain enriched across some of these DE gene sets. However, they 10 were mostly still generic or blood related (e.g., GO:0030218 erythrocyte differentiation, GO:0005576 11 extracellular region), although a few were potentially interesting (e.g., GO:0048812 neuron projection 12 morphogenesis), especially given the tiny number now present. 13
Identification of functional outliers 14
Statistical significance does not arise from analysis within each family (n=1), but by recurrence of high 15 fold-change genes across families. To detect and characterize functional outliers, we begin by measuring 16 the recurrent overlap of the top up and down regulated genes ( Figure 5B ). Relatively few genes 17 overlapped between the families, with at most 26/100 overlapping between any pair of families. To 18 calculate the probability of recurrence of differentially expressed genes ( Figure 5C ), we used the 19 binomial distribution. A modest number of genes are significant across the families at this level, but 20 mostly due to common functional variation (red highlighted genes in Figure 5C ). We see that once we 21 filter common co-expression, we lost almost all recurrence ( Figure 5D) , with a very small number of 22 functional outliers remaining. Note that this is, if anything, a mildly positive result since "easy" or 23 promiscuous significance is precisely what functional outliers should select against. 24
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The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/128439 doi: bioRxiv preprint first posted online Apr. 18, 2017; We once again performed a threshold analysis, to observe the trends and effects on our results when 1 we alter the stringency of our parameters. As in the previous analysis, we varied the number of genes to 2 consider as a hit. The number of recurrent genes increases the more genes we take as differentially 3 expressed (dashed lines in Figure 5E ). Of course, this is balanced by the threshold required for a gene to 4 be considered as significant (grey lines in Figure 5E ). There is generally an increase in the number of 5 significantly recurrent genes with per family fold-change "hit" thresholds into the low 100s. After 6 thresholding a hit to the top 200 genes, no genes are significantly recurrent for the up-regulated genes, 7 and the same drop-off occurs at close to 400 genes for the down-regulated genes ( Figure 5E ), when the 8 threshold required to pass as recurrent jumps. These trends repeat, as we see more significantly 9 recurrent genes farther down in the fold-change threshold. However, these genes are not the same as 10 those found as recurrent in the earlier part of the analysis and given the fold changes by this stage (500 11 down in the list for some families) are hard to discern from potentially overlapping technical noise (i.e., 12 SEQC recommendations of < log2 FC 1 and low expressing (Consortium, 2014) ). The analysis generally 13 suggests a threshold of top 100 is reasonable, which was chosen based on our sense of what is typically 14 regarded as biologically plausible. In the reverse, to the extent the statistics support what is usually an 15 ad hoc decision motivated by biological intuitions, it suggests our analytical framework is well-calibrated 16 to the underlying biology. 17
Filtering for co-expression blocks leaves three genes as significantly recurrent ( Figure 5D Genomics, 2014). It is almost a uniquely strong candidate for missense variation to play a role in a 3 complex-phenotype neuropsychiatric disorder, and is a "hit" in 4-5 (depending on threshold) of our 6 4 families. Given this, it is interesting that only in family 4 is this gene not differentially expressed at all. 5
Family 4 is the only family in which the mutation in the proband is a CNV duplication, and this proband is 6 not characterized as possessing one of the key phenotypic features making this disorder distinctive with 7 respect to other neuropsychiatric diseases (e.g., the unusual intergluteal crease). 8
The other strong outlier candidate, also seen in 4-5 of the 6 families, was the insulin-like growth factor-9 binding protein 3 IGFBP3 (FDR <2.63e-05). This gene was also not found in family 4, and also not at our 10 default settings in family 3. In this case, it showed modest differential expression in both these families, 11 but had high variability between the parents and so was filtered away in family 3 (see experimental 12 procedures), and in family 4 was below the default threshold. In general, and in contrast to CACNA1I, 13 IGFBP3 showed at least some co-expression with other DE genes. 14
Exploiting functional outliers in conventional case-control analysis 15
Our data can be repurposed as a conventional case-control analysis with 6 batches blocked between 16 case and control but not controlled for age and sex. We repeated the differential expression analysis, 17 but this time using all the probands and all the parents as if a case-control while also correcting for 18 batch effects. Interestingly, CACNA1I and IGFBP3 are the top ranked candidates ( Figure 6A) . The 19 similarity of our outlier-based DE and regular case-control DE result might seem to negate the necessity 20 of detecting outliers, but we suggest the opposite is true. It is startling that we remove the majority of 21 hits within each family as being definitely not outliers and still obtain the same results as case-control 22
analyses from the entire cohort. The strong implication is that we are, in essence, predicting which hits 23
. CC-BY-NC-ND 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/128439 doi: bioRxiv preprint first posted online Apr. 18, 2017; within a family are unlikely to be replicated across the entire cohort (those that filter away). To better 1 quantify this possibility, we downsampled the families assessed for both case-control and recurrence (of 2 outliers) analysis and use the top hits within the whole case-control cohort as positives to assess the 3 performance of the downsampled data. We use the rankings of these two genes as our true positive 4 set, for all family-proband combinations (see experimental procedures), including family 4. Although 5 recurrence is not significant when using only two families, we still see on average much better ranks 6 when using the recurrence analysis as compared to the case-control analysis (Figure 6C and D) , typically 7 varying by orders of magnitude in precision. As we increase the number of cases, the difference in 8 average rank shrinks, although only because the recurrence reaches near perfect performance after only 9 a small number of probands. As suggested, the identified systems signal associated with all co-10 expression and enrichment is precisely what is averaged away as the cohort is expanded across all 11 families; however, the same signal can be identified within families by filtering away the systems signal 12 directly. 13 Having characterized where DE arises within this data when assessed by one pipeline, we wanted to 14 determine the generalizability to DE pipelines other than the comparatively simple one we employed. To 15 this end, we re-analyzed our data using DESeq2, a popular mainstream choice (Love et al., 2014) . The 16 hit lists identified are highly similar as is the presence of co-expression blocks within each analysis 17 ( Figure S4 ). This seems plausible to us because those signals are real and biological, just less likely to be 18 associated with a rare disease (which DESeq2 cannot assume). Moreover, those co-expression blocks 19 typically rank above the positive hits validated by the cohort as a whole, with a mean rank (of both 20 CACNA1I and IGFBP3) improving from ~58 th to ~9 th after filtering, similar to our earlier results ( Figure  21 S5), although recurrence drops once we filter too stringently. While this suggests that identification of 22 functional outliers is largely robust to DE pipeline, numbers of genes to include (e.g., top 100), exact cut 23 depths, and other factors which were robust within our data may vary in unassessed pipelines. There is 24
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properties. 2
More broadly, our observation is that the benefit of assessing the individual families separately is the 3 ability to filter off pathways that are generic, but do characterize that sample-set idiosyncratically (i.e., 4 are strong biological artifacts of that data unrelated to diseases). While co-expression blocks are still 5 visible in the top 100 candidate genes in the full case-control version of our analysis, the pattern has 6 become blurred ( Figure 6B ) and filtering parameters may need to be carefully considered in high 'n' 7 studies. 8
Discussion
9
The two main contributions of this work are the description of a means of determining functional 10 outliers in expression data and providing a proof-of-principle of their importance in the analysis of the 11 TAF1 cohort. There are many considerations which motivated our interest into whether functional 12 outliers exist. Medically, functional outliers seem like unusually strong candidates to have a retained 13 signal across tissues, including those not principally affected by the disease. In an analysis where genes 14
show some joint change in activity reflective of shared regulation within a pathway, it is likely that the 15 pathway is itself variable across tissues, especially if the disease is. In contrast, functional outliers look 16 like they have "missed" regulation to some degree. When other regulated processes change as expected 17 across tissues, a gene that is not regulated in one tissue will be more likely to also be unregulated in 18 other tissues. Hypothetically, this could be because the system cannot buffer the transcriptional 19 variation: new interactions are generated or control is lost. Similarly, functional outliers may represent a 20 critical point of causation for rare disorders if they provide a substantial portion of the signal; in essence, 21 serving as a bottleneck through which all later joint dysregulation passes. 22
From the perspective of network biology, functional outliers are of interest because they are more likely 1 to occur in topologically unusual locations in gene networks and particularly may overlap with "critical 2 connections" encoding non-redundant functional information (Gillis and Pavlidis, 2012). Along related 3 lines, our approach for identifying functional outliers subtly resembles permutation testing in 4 enrichment software, since that holds constant correlations between genes; it is this very correlation we 5 are estimating from other data. More broadly, as the significant remainder from many types of 6 conventional analysis, the presence of functional outliers helps define "unknown unknowns" in 7 interpreting expression profiles. For all these reasons, we expected the presence or absence of 8 functional outliers to be worthy of consideration. What was unexpected, however, was the large degree 9 to which selecting for them appeared to improve the interpretability of our expression data. 10 This is not to say that functional outliers dominate the underlying biology, even of rare disease. We do 11 not think this is the case, but the picture our results paint is that common functional co-variation does 12 dominate the space of false positives. Thus, even though all our samples are derived from blood, genes 13 related to blood show differential expression and functional enrichment because the precise degree of 14 signal is not held constant from sample to sample. From that perspective, identifying functional outliers 15 is simply a form of "data clean-up", albeit a comparatively challenging one since it is untargeted 16 biological signals, rather than technical ones, which are being cleaned up. After this clean-up, rather 17 than finding lots of commonplace signal, we find a very small number of potential candidates. 18
The clearest candidate, CACNA1I appears highly plausible both from the disease-variation known to be 19 linked to it, and also from phenotype overlaps in knock-out models. Mouse knock-outs show a poor 20 contact righting reflex, change in number of caudal vertebrae, and an impaired auditory response 21 (Koscielny et al., 2014) . In comparison, the probands suffer from hypotonia, an unusual intergluteal 22 crease, a prominent protruding coccyx, and impaired hearing (O'Rawe et al., 2015). While our analysis 23
does not incorporate the post-hoc observation that family 4 is distinct from the others with respect to 1 this phenotype (and genotype), the fact this observation was brought to light specifically by the 2 expression data seems promising since an expression-first characterization of disease would be highly It is possible to imagine a number of factors which made functional outliers of particular importance to 12 our study. To whatever extent this is true, it may make them of less value or importance in other 13
analyses. For example, as our samples were derived from blood, it is possible that our RNA-seq analysis 14 was in particular need of the type of clean-up filtering for commonplace co-expression which our 15 approach provides. Or in a nearly opposite view, it is possible our data is unusually clean due to the 16 clarity and homogeneity of the disorder we were studying and that in most cases, recurrence reflecting 17 broader phenotypic overlaps can only arise downstream of any functional outliers. And, of course, many 18 of the caveats that would apply to any expression analysis can apply to ours and, in particular, gene-19 specific variation in the degree to which we are powered to detect changes may be important; we 20 followed the guidelines derived from the SEQC experiments, but genes can be outliers for novel reasons 21 and care will need to be taken. For instance, it would be problematic if a gene passed co-expression 22 blocking simply because it was more variable than its functional group in general. In our analysis, signals 23 were clear enough to make results robust to these considerations, and while we have provided a 24 .
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Experimentalists can directly use the co-expression block data we have provided to assess their own 4 results in more detail. We suggest assessment for functional outliers is a useful characterization of 5 expression data wherever rare expression variation potentially plays a role. 6
Conclusion
7
In our TAF1 disease cohort, most of the differential expression reflects co-variation that is expected 8 between genes, indicating differences between the salience of those signals unrelated to disease. 9
Filtering off these signals reveals functional outlier genes, whose presence as differentially expressed is 10 specifically not expected in the context of the other hits within an experiment. The most prominent 11 functional outlier, CACNA1I, is a very plausible candidate to play a molecular role in TAF1 syndrome. 12
Characterization of functional outliers should be incorporated as a default into studies of rare disorders 13 and possibly more broadly, where unique phenotypic convergence is present. 14
Experimental Procedures
15
RNA-sequencing and processing 16
We collected blood from 6 of the pedigrees, renaming them from the original work and listed in Table 1 . 17 For more information on the families, refer to (O'Rawe et al., 2015).For RNA sequencing, blood was 18 collected in PAXgene Blood RNA tubes and the RNA was isolated with the PAXgene Blood RNA kit 19 (QIAGEN) according to the manufacturer's recommendations. The RNA was quantified using NanoDrop. 20
To increase downstream sensitivity, globin mRNA was depleted from the samples using the GLOBINclear 21
Kit (Life Technologies). Briefly, the RNA was precipitated with ammonium acetate, washed and 22 resuspended in 14 µl TE (10 mM Tris-HCl pH 8, 1 mM EDTA). Subsequently, for each sample 1.1 µg RNA 23 .
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Bioanalyzer High Sensitivity DNA chip (Agilent) and the concentration was measured using Qubit dsDNA 5 HS Assay (Life Technologies). To eliminate primer dimers in the libraries, additional purifications were 6 performed using the Agencourt AMPure XP system (Beckman Coulter). The libraries were pooled to 2-10 7 nM total concentration and sequenced on an Illumina NextSeq 500, PE100, mid output. Libraries were 8 generated independently for each family and family-pools multiplexed and sequenced on separate 9
lanes. ERCC spike-ins included in the preparation were not used for normalization, but rather as a 10 measure of quality control. Families 2, 3 and 6 showed the lowest variation in the ERCCs between family 11 members, while family 4 and 5 had higher technical noise ( Figure S3 ). Reads were filtered for QC and 12 artifacts using the fastX toolbox, and then the reads were paired up using an adapted python script 13 (https://github.com/enormandeau/Scripts/blob/master/fastqCombinePairedEnd.py). The reads were 14 aligned to the genome (GRCh38, GENCODE v22 (Harrow et al., 2012)) using STAR (2.4.2a) (Dobin et al., 15 2012 ). The data has been deposited in GEO/SRA under accession number GSE84891. 16
Data collection and co-expression analysis 17
RNA-seq expression data was collected from Gemma (Zoubarev et al., 2012) for human subjects. From 18 the collection, we selected 75 expression experiments (3,653 samples) that we could ascertain were of 19 tissues and not cell lines. These are listed in Table S1 . For each experiment, we consolidated our list of 20 genes/transcripts to the 30K with Entrez gene identifiers, and did not limit either expression level or 21 occurrence of expression. For each experiment with at least 10 samples, we generated a co-expression 22 network using Spearman's correlation coefficient (Ballouz et al., 2015) and calculated the frequency that 23 a pair of genes was negatively co-expressed (Spearman's correlation coefficient r s <0). 24 .
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To measure the information content of the network, we use the performance of the n-fold cross 2 validation task of a neighbor voting algorithm. If we can hide known information about genes in a gene 3 set and then "learn" this information from the network, then our network has, to a degree, information 4 that is reflective of the known biology of that GO term. This is based on the "guilt-by-association" 5 principle, which states that genes with shared functions should be connected preferentially in the 6 network. The reported performance metric from this task is the averaged AUROC (area under the ROC 7 curve) for each group across the n-folds. We used the Bioconductor package EGAD ( the network is unusual in the degree to which it is not linking genes by function. The AUROC can be 13 converted into a p-value by virtue of its overlap with the Mann-Whitney test-statistic (after a 14 standardization), but because of our data size, even modest deviations from 0.5 are extremely 15
significant. 16
Differential expression analysis 17
We calculate a fold change between the parents and the probands for the differential expression 18 analysis. We first calculate the CPM (counts per million) for each individual, and then take the average 19 CPM for the parents and compare it the CPM of the proband. We take the log2 of the CPM (adding 1) of 20 the ratio of these values. To exploit within family variance to detect noisy genes, we remove genes that 21
showed strong differential expression between the parents themselves (i.e., top 100 up-regulated and 22 top 100 down-regulated genes). After removing these highly variable genes, we take the top 100 up-23 and down-regulated genes based on ranking the fold change. Note that each family-specific analysis is 24
perfectly confounded with age, and strongly confounded with sex. However, because these factors are 1 frequently present in other data, genes jointly affected by these conditions should co-vary across 2 previous data and thus not generate artefactual outliers. We assess each family in a separate batch 3 (library preparation and sequencing run). This holds likely technical variation constant in each family and 4 independent across families, so that gene-level recurrence is not expected to differ from the null. By 5 way of analogy, our experimental design resembles the analysis of de novo variants in DNA analyses, in 6 which as many factors as possible are held constant in the control group for the proband (e.g., siblings, 7 parents). For the case-control version of the analysis, we take all the parents as controls, and all the 8 probands as cases, and perform the standard DE analysis. First we run Combat on all the samples, 9 making it aware of the model and the batches. We then average the parents and the probands CPM 10 expression levels, and calculate the fold change, and use both the one-sided and two-sided Wilcoxon-11 rank-sum tests to calculate a p-value, adjusted for multiple tests using Benjamani-Hochberg correction 12 (FDR, p.adjust in R). For the DESeq2 version of the analysis, we used the counts data filtering away low 13 expressing genes, and ran the default steps. All DE methods output the log2 fold-change and a p-value 14 for each gene. We rank genes based on fold-change in the within family analysis, and p-value for the 15 case-control analyses and all DESeq2 analyses. 16
The downsampling experiment involved taking combinations of the families and performing the case-17
control DE, such that once again the probands were the cases and the parents the controls. This was 18 done for all 56 combinations of 2,3,4 and 5 probands across our 6 families. For each combination, we 19 used the Combat corrected data and ranked genes based on the adjusted p-value of the Wilcoxon test 20 (wilcox.test, p.adjust in R). 21
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GO enrichment 1
To calculate GO term enrichment of the top differentially expressed genes, we used a simple gene set 2 enrichment based on the hypergeometric test. For each gene set in GO, we calculate the significance of 3 the overlap of the differentially expressed genes and that GO group, correcting for multiple tests with 4
Benjamani-Hochberg (FDR, p.adjust in R). 5
Module detection and outlier analysis 6
To measure the joint differential activity of a set of genes, we extract the sub network of these genes 7 from the frequency of co-expression network. Then, taking threshold on the median value, we use this 8 binary network as distance matrix, and perform a hierarchical clustering of the genes. This clustering 9
returns genes that are closer in distance, and we use this dendrogram to define modules within the 10 data. We used the R dynamicTreeCut (Langfelder et al., 2008) package to select modules within the data 11 of a minimum cluster size 2. We used these clusters or modules to define our co-expression blocks, and 12 filtered away blocks greater than size 5, to keep "functional-outliers". We calculate the significance of 13 overlap using Fisher's exact test (phyper in R). We calculate the significance of recurrence of the 14 differentially expressed genes using the binomial test (pbinom in R), and then correcting for multiple 15 tests using either Bonferroni (FWER) or Benjamini-Hochberg (FDR, p.adjust in R). Code and the network 16 is available for download from our github repository (https://github.com/sarbal/redBlocks). 14 . Tables   1   Table 1 1   Table S1 . List of experiments used to generate co-expression networks, related to Figure 2 . 2   Table S2 . List of top 1000 differentially expressed genes for each family, related to Figures 3-5 . 3   Table S3 . GO enrichments for top 100 up and down regulated genes for each family, related to Figures 4 3-5. 5   Table S4 . List of top 1000 differentially expressed genes for the case-control analysis related to Figure 6 . 6 Table S5 . Library indices for RNA-seq analysis of TAF1 families, related to Table 1 . 
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